LaingBuisson News Former CEO and president of The Revenio Group, Timo Hildén, has been appointed chairman of the board of directors at Finnish medtech startup, Nukute. Nukute develops high-tech tools for the diagnosis and testing of respiratory diseases and conditions, including the home sleep apnea testing (HSAT) product. Alongside Hildén, Nukute appointed another two new members to the board: Tommi Mäkelä as the representative of the Pharmacy Pension Fund (Finland), and Frans Wuite, CEO of Kompassi. Johannes Gullichsen, Pekka Virtanen and Timo Laitinen continue as members. “Nukute dem...